State University of New York at Buffalo

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1846-05-11

Employees: 1K

Market Cap: -

Website: http://www.buffalo.edu

Clinical Trials

Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Behavioral: Self Administered Cognitive Behavior Therapy
Behavioral: Behavioral Education and Supportive Therapy
Behavioral: Therapist Administered Cognitive Behavior Therapy

First Posted Date: 2008-08-21

Last Posted Date: 2022-08-05

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 436

Registration Number: NCT00738920

Locations: 🇺🇸
University at Buffalo School of Medicine, Buffalo, New York, United States
🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Etanercept in New Onset Type 1 Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Etanercept
Drug: Placebo

First Posted Date: 2008-08-08

Last Posted Date: 2023-04-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 18

Registration Number: NCT00730392

Cost-effectiveness of Family Based Pediatric Obesity Treatment

Not Applicable

Completed

Conditions: Quality of Life
Weight Change

Interventions: Behavioral: Individual Behavior Modification
Behavioral: Family-based behavior modification

First Posted Date: 2008-07-16

Last Posted Date: 2022-05-16

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 50

Registration Number: NCT00717132

Locations: 🇺🇸
SUNY @ Buffalo, Buffalo, New York, United States

Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders

Recruiting

Conditions: Dystonia
Parkinsonism

First Posted Date: 2008-05-22

Last Posted Date: 2024-04-15

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 198

Registration Number: NCT00682513

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
University of California, Davis, Sacramento, California, United States
🇺🇸
University at Buffalo, Buffalo, New York, United States

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

Phase 3

Completed

Conditions: Hypertension

Interventions: Drug: Carvedilol CR
Drug: Valsartan

First Posted Date: 2008-04-14

Last Posted Date: 2022-05-27

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 30

Registration Number: NCT00657241

Locations: 🇺🇸
Erie County Medical Center, Buffalo, New York, United States

Buprenorphine as a Treatment in Opiate Dependent Pain Patients

Phase 4

Terminated

Conditions: Refractory Pain
Opiate Addiction

Interventions: Drug: buprenorphine/naloxone

First Posted Date: 2007-11-02

Last Posted Date: 2011-02-17

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 12

Registration Number: NCT00552578

Locations: 🇺🇸
Erie County Medical Center, Buffalo, New York, United States

"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Placebo
Drug: Lidocaine Cream 4%

First Posted Date: 2007-09-21

Last Posted Date: 2022-12-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 70

Registration Number: NCT00533468

Locations: 🇺🇸
Women's and Children's Hospital of Buffalo, Buffalo, New York, United States

Facilitating Aftercare for Alcohol Detox Patients

Not Applicable

Completed

Conditions: Alcohol Abuse
Alcohol Dependence

Interventions: Behavioral: Peer-Twelve Step Facilitation (P-TSF)
Behavioral: Motivation Enhancement Therapy (MET)

First Posted Date: 2007-08-09

Last Posted Date: 2020-10-14

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 150

Registration Number: NCT00513708

Locations: 🇺🇸
Erie County Medical Center, Buffalo, New York, United States

CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study

Not Applicable

Withdrawn

Conditions: Obstructive Sleep Apnea

First Posted Date: 2007-07-06

Last Posted Date: 2020-11-25

Lead Sponsor: State University of New York at Buffalo

Registration Number: NCT00497640

Locations: 🇺🇸
State University of New York at Buffalo, Buffalo, New York, United States

Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2007-04-20

Last Posted Date: 2020-12-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 150

Registration Number: NCT00463710

Locations: 🇺🇸
The Jacobs Neurological Institute, Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy